A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

Azithromycin a Treatment for Pulmonary Sarcoidosis

NCT04020380 ·Status: COMPLETED ·Phase: PHASE2

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677543 ·Status: COMPLETED ·Phase: PHASE3

Trial of Antimycobacterial Therapy in Sarcoidosis

NCT01074554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex

NCT00298922 ·Status: UNKNOWN ·Phase: PHASE2

Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

NCT01097005 ·Status: COMPLETED

Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)

NCT00358462 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677569 ·Status: COMPLETED ·Phase: PHASE3

Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection

NCT03421743 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

NCT05716425 ·Status: COMPLETED ·Phase: PHASE3

TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis

NCT00523926 ·Status: COMPLETED ·Phase: PHASE2

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

NCT01169038 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever

NCT05398055 ·Status: RECRUITING ·Phase: PHASE3

Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

NCT04618198 ·Status: UNKNOWN ·Phase: PHASE3

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

NCT05824988 ·Status: RECRUITING

Short-term Bactericidal Effect of Contezolid in MAC-PD

NCT07084402 ·Status: RECRUITING ·Phase: PHASE4

Mycobacterium Avium Intracellulare Complex (MAC) Study

NCT00826423 ·Status: COMPLETED

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

NCT02454205 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Shortening Treatment by Advancing Novel Drugs

NCT02342886 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections

NCT02355015 ·Status: UNKNOWN

Intensified Short Course Regimen for TBM in Adults

NCT05917340 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Azithromycin for Meningococcal Carriage

NCT06618534 ·Status: RECRUITING ·Phase: PHASE2

Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide

NCT02120638 ·Status: UNKNOWN ·Phase: PHASE3

Scrub Typhus Antibiotic Resistance Trial

NCT03083197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Toxicity of Treatments for Non-tuberculous Mycobacterial Infections in Cancer Patients or Not

NCT05030701 ·Status: UNKNOWN

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

NCT05382312 ·Status: COMPLETED ·Phase: PHASE2